Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism.

Szántó M., Bai P.

Narrative Review on Type 2 Diabetes, published in Genes Dev (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Genes Dev (2020)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
32029456
PMCID
PMC7050491
DOI
10.1101/gad.334284.119
Citations
72

Abstract (original English)

Poly(ADP-ribose) polymerases (PARPs or ARTDs), originally described as DNA repair factors, have metabolic regulatory roles. PARP1, PARP2, PARP7, PARP10, and PARP14 regulate central and peripheral carbohydrate and lipid metabolism and often channel pathological disruptive metabolic signals. PARP1 and PARP2 are crucial for adipocyte differentiation, including the commitment toward white, brown, or beige adipose tissue lineages, as well as the regulation of lipid accumulation. Through regulating adipocyte function and organismal energy balance, PARPs play a role in obesity and the consequences of obesity. These findings can be translated into humans, as evidenced by studies on identical twins and SNPs affecting PARP activity.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adenosine Diphosphate RiboseAdipose TissueCarbohydrate MetabolismCell DifferentiationHumansLipid MetabolismPoly(ADP-ribose) Polymerases

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research